Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1100 µg Brimonidine Tartrate Implant
(D07540)		1件: Brimonidine1件: Brimonidine (D07540) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
2200 µg Brimonidine Tartrate Implant
(D07540)		1件: Brimonidine1件: Brimonidine (D07540) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
3400 µg Brimonidine Tartrate Implant
(D07540)		1件: Brimonidine1件: Brimonidine (D07540) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
4Brimonidine
(D07540)		1件: Brimonidine1件: Brimonidine (D07540) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 13, 90 💬
5Brimonidine tartrate
(D07540)		1件: Brimonidine1件: Brimonidine (D07540) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 13, 90 💬
6Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System
(D07540)		1件: Brimonidine1件: Brimonidine (D07540) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬